These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 6457930)

  • 1. Humoral inhibitors of the immune response in uremia. IV. Effects of serum and of isolated serum very low density lipoprotein from uremic rats on cellular immune reactions in vitro.
    Raskova J; Raska K
    Lab Invest; 1981 Nov; 45(5):410-7. PubMed ID: 6457930
    [No Abstract]   [Full Text] [Related]  

  • 2. Humoral inhibitors of the immune response in uremia. III. The immunosuppressive factor of uremic rat serum is a very low density lipoprotein.
    Raska K; Morrison AB; Raskova J
    Lab Invest; 1980 Jun; 42(6):636-42. PubMed ID: 6446621
    [No Abstract]   [Full Text] [Related]  

  • 3. Humoral inhibitors of the immune response in uremia. V. Induction of suppressor cells in vitro by uremic serum.
    Raskova J; Raska K
    Am J Pathol; 1983 May; 111(2):149-55. PubMed ID: 6221666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular immunity and lymphocyte populations in developing uremia in the rat.
    Raskova J; Czerwinski DK; Shea SM; Raska K
    J Exp Pathol; 1986; 2(4):229-45. PubMed ID: 2946817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral inhibitors of the immune response in uremia. I. Effect of serum and of the supernatant of spleen cultures from uremic rats on the mixed lymphocyte reaction.
    Raskova J; Morrison AB
    Lab Invest; 1978 Jan; 38(1):103-9. PubMed ID: 146111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro responses of BN strain inbred rats.
    Shonnard JW; Davis BK; Nethery L; Cramer DV
    Transplant Proc; 1981 Jun; 13(2):1390-3. PubMed ID: 6972641
    [No Abstract]   [Full Text] [Related]  

  • 7. Humoral inhibitors of the immune response in uremia. II. Further characterization of an immunosuppressive factor in uremic serum.
    Raskova J; Morrison AB; Shea SM; Raska K
    Am J Pathol; 1979 Nov; 97(2):277-90. PubMed ID: 230740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response in experimentally induced uremia. II. Suppression of PHA response in uremia is mediated by an adherent, Ia-negative and indomethacin-insensitive suppressor cell.
    Alevy YG; Slavin RG
    J Immunol; 1981 May; 126(5):2007-10. PubMed ID: 6163826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nutrition, immunology, and renal disease.
    Glassock RJ
    Kidney Int Suppl; 1983 Dec; 16():S194-8. PubMed ID: 6234423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Humoral factors. Immunologic enhancement.
    Batchelor JR; Welsh KI; Burgos H
    Transplant Proc; 1977 Mar; 9(1):931-6. PubMed ID: 141143
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.
    Murphy B; Akalin E; Watschinger B; Carpenter CB; Sayegh MH
    Transplant Proc; 1995 Feb; 27(1):409-10. PubMed ID: 7879041
    [No Abstract]   [Full Text] [Related]  

  • 12. Intragraft immune events causing vascularized organ graft rejection.
    Strom TB; Carpenter CB; Tilney NL; Suthanthiran M; Catto GR; Lundin AP; Milford EL
    Transplant Proc; 1978 Jun; 10(2):389-94. PubMed ID: 354128
    [No Abstract]   [Full Text] [Related]  

  • 13. Uremic escape of renal allograft rejection.
    van Schilfgaarde R; van Breda Vriesman PJ
    Neth J Surg; 1981 Oct; 33(4):173-80. PubMed ID: 7029351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunity and hypersensitivity in Hodgkin's lymphoma].
    Leoni P; Marchegiani G; Montillo M; Centurioni R; Montroni M; Danieli G
    Minerva Med; 1982 May; 73(20):1361-9. PubMed ID: 6210855
    [No Abstract]   [Full Text] [Related]  

  • 15. The association of immune responsiveness, mixed lymphocyte responses, and Ia antigens in natural populations of Norway rats.
    Shonnard JW; Davis BK; Cramer DV; Radka SF; Gill TJ
    J Immunol; 1979 Aug; 123(2):778-83. PubMed ID: 156763
    [No Abstract]   [Full Text] [Related]  

  • 16. Maturation of functional T-lymphocyte subpopulations in the rat.
    Greiner DL; Reynolds GW; Lubaroff DM
    Thymus; 1982 Feb; 4(2):77-90. PubMed ID: 6977897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of T lymphocyte self-reactivity in aging inbred rats: in vitro studies with a model of experimental autoimmune orchitis.
    Kyewski B; Wekerle H
    J Immunol; 1978 Apr; 120(4):1249-55. PubMed ID: 147906
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response in experimentally induced uremia. V. Description of a model for chronic uremia in the rat that produces a long-term suppressive effect on T cell responses to mitogens.
    Alevy YG; Mueller KR; Hutcheson P; Slavin RG
    J Lab Clin Med; 1983 May; 101(5):717-25. PubMed ID: 6601172
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is cell-mediated immunity in the uremic patient affected by blood transfusion?
    Fehrman I; Ringdén O; Möller E; Lundgren G; Groth CG
    Transplant Proc; 1981 Mar; 13(1 Pt 1):164-6. PubMed ID: 6455789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.